Entering text into the input field will update the search result below

Moleculin announces proposed underwritten public offering

  • Moleculin Biotech (NASDAQ:MBRX) announces that it intends to offer and sell shares in an underwritten public offering.
  • The company plans to use the net proceeds of the offering to fund its planned clinical trials and preclinical programs among other things.

Recommended For You

About MBRX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MBRX--
Moleculin Biotech, Inc.